African-Americans may receive different advice on statin therapy

March 19, 2017
Micrograph of a heart with fibrosis (yellow) and amyloidosis (brown). Movat's stain. Credit: Nephron/Wikipedia

African Americans experience a disproportionately high risk of cardiovascular disease, and statin treatment can be an important tool to lower the risk of plaque building up in the arteries.

But statin from different organizations vary, according to a new paper published in JAMA Cardiology and presented at the American College of Cardiology's annual Scientific Sessions.

The 2013 American College of Cardiology and American Heart Association guidelines dramatically increased the number of people eligible for statins. Recent guidelines developed by the U.S. Preventative Services Task Force, or USPSTF, focus on a narrower population using clinical risk factors.

"We found one in four African Americans who would have been recommended for statin therapy under the ACC/AHA guidelines would not be recommended under new USPSTF guidelines," says Venkatesh Murthy, M.D., Ph.D., co-senior author and cardiologist at Michigan Medicine. "We wanted to determine whether the right people were being identified for statin therapy."

Murthy, an assistant professor, led a study of 2,812 African American adults who participated in the Jackson Heart Study in Jackson, Mississippi and were at risk for . In 1,743 of the participants, Michigan Medicine and Harvard University researchers also analyzed the impact of calcification of the coronary arteries, which is associated with cardiovascular events, such as stroke or heart attack.

The study determined the stricter USPSTF guidelines did not identify as many individuals with coronary calcification as the ACC/AHA guidelines.

"Because the USPSTF guidelines target those with the highest risk of atherosclerotic cardiovascular disease, they also may miss some African Americans with some vascular calcification and low or moderate risk," says Ravi V. Shah, M.D., co-senior author from Massachusetts General Hospital and Harvard Medical School.

Researchers say the results support further personalization of recommendations for , including targeted imaging.

This is the latest work to come out of the Jackson Heart Study, the largest single-site, prospective, epidemiologic investigation of among African Americans. The full study includes a cohort of more than 5,000 patients who live in rural and urban areas of three counties around Jackson, Mississippi. The subjects were each examined three times over a period of nine years, beginning in 2000.

Explore further: European, American guidelines lead to different recs for statins

More information: Ravi V. Shah et al, Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals, JAMA Cardiology (2017). DOI: 10.1001/jamacardio.2017.0944

Related Stories

European, American guidelines lead to different recs for statins

September 26, 2016
(HealthDay)—European and American guidelines lead to different recommendations for statin therapy, according to a study published online Sept. 21 in JACC: Cardiovascular Imaging.

Most seniors eligible for statin Rx under new guidelines

November 25, 2014
(HealthDay)—Most older Americans qualify for treatment with statins under new guidelines for the treatment of blood cholesterol released late last year by the American College of Cardiology and the American Heart Association. ...

New guidelines for statin eligibility improve prediction of cardiovascular risk

July 14, 2015
The new guidelines for determining whether patients should begin taking statins to prevent cardiovascular disease issued in 2013 by the American College of Cardiology (ACC) and the American Heart Association (AHA) are more ...

Reporting Agatston scores with chest CT leads to cardiovascular risk reclassification

April 23, 2015
The assessed risk of more than 65% of patients without established cardiovascular disease who were evaluated for coronary artery calcification via ungated chest CT was reclassified after undergoing Agatston-scored ungated ...

Newly diagnosed diabetes increases risk of heart attack, stroke even among statin users

May 18, 2016
Postmenopausal women with newly diagnosed diabetes have a significantly increased risk of atherosclerotic cardiovascular disease whether or not they take statin drugs, according to the results of a new study led by researchers ...

USPSTF issues recommendations regarding use of statins for the prevention of cardiovascular disease

November 13, 2016
The U.S. Preventive Services Task Force (USPSTF) has issued a recommendation statement regarding the use of statins for primary prevention of cardiovascular disease in adults. The report appears in the November 15 issue of ...

Recommended for you

Research suggests new pathways for hyperaldosteronism

December 7, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), in collaboration with researchers at Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the ...

One-dose gene therapy produces clotting factor, safely stops bleeding in hemophilia B patients

December 6, 2017
A team of gene therapy researchers has reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B. A single intravenous infusion of a novel bioengineered gene therapy treatment ...

Clot-busting drugs not recommended for most patients with blood clots

December 6, 2017
Not all patients with blood clots in their legs - a condition known as deep vein thrombosis - need to receive powerful but risky clot-busting drugs, according to results of a large-scale, multicenter clinical trial.

Mitochondrial protein in cardiac muscle cells linked to heart failure, study finds

December 5, 2017
Reducing a protein found in the mitochondria of cardiac muscle cells initiates cardiac dysfunction and heart failure, a finding that could provide insight for new treatments for cardiovascular diseases, a study led by Georgia ...

Blood pressure declines 14 to 18 years before death

December 4, 2017
Blood pressure in the elderly gradually begins to decrease about 14 or so years before death, according to a new study published today in the JAMA Internal Medicine.

Study links common male medical condition and vascular disease

December 1, 2017
Men who suffer symptoms from varicoceles, enlarged veins in the scrotum, are more likely to develop vascular disease and metabolic disease, such as diabetes, according to a study by Stanford University School of Medicine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.